Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research
  • Market Analysis
  • Analyst Ratings
  • Top Stocks
  • Contact

Browse research

Author: Muzzammil Ahmad

Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product/services forecast as indicated by major brokers covering the stock.
Adobe Inc. (ADBE) William Blair Downgrades to Market Perform
Market News & Insights Jun 12, 2024

Adobe’s Q2 Earnings Preview: Analyst Estimates Positive Results

Adobe is set to report its fiscal second-quarter earnings on June 13th, and analysts are anticipating a strong showing. Wall Street estimates…

#Artificial Intelligence #Earnings #U.S. Markets
BHP's Long-Term Uranium Play Offers Diversification for Clean Energy Investors
Market News & Insights Jun 12, 2024

BHP’s Long-Term Uranium Play Offers Diversification for Clean Energy Investors

BHP Group Limited (BHP: NYE), a leading global resource company, is known for its dominance in the iron ore, copper, and coal…

#Mining Stocks
https:/c3-ai-vs-palantir-wedbush-offers-insights/
Market News & Insights Jun 12, 2024

C3.ai vs. Palantir: Wedbush Offers Insights

Artificial intelligence is revolutionizing industries, and investors are eager to capitalize on this growth. Wedbush, a prominent investment firm, has weighed in…

#Artificial Intelligence #technology stocks
add stock symbols: "3M Co: Jefferies lowered its price target to $160 from $180, citing a weaker macro backdrop and increased demand volatility from tariffs. Bank of America Corp: The bank agreed to pay $72.5 million to settle a lawsuit tied to Jeffrey Epstein-related allegations, resolving the matter without admitting wrongdoing. BlackRock Inc: The firm participated in a $57.64 million funding round for IQM Quantum Computers to support its growth and upcoming public listing. Boston Scientific Corp: Jefferies cut its price target to $110 from $120 due to lower valuation multiples and limited upside from recent developments. Chevron Corp: Its Wheatstone LNG facility in Australia will take several weeks to return to full production after cyclone damage, contributing to global supply disruptions. Eli Lilly and Co: The company is seeking higher UK drug prices and rebate reforms to support investment, while also entering a potential $2.75 billion AI drug development partnership. Hartford Insurance Group Inc: KBW downgraded the stock to Market Perform from Outperform due to concerns over liability reserve adequacy. Nexstar Media Group Inc: A U.S. judge ordered the company to keep Tegna’s assets separate temporarily while reviewing antitrust concerns related to its $3.54 billion acquisition. Nike Inc: The company is facing mounting challenges in China from weaker consumer demand and rising competition from domestic brands, pressuring its market share. Nvidia Corp.  is now trading at its lowest price-to-earnings multiple in seven years as broader market selloffs driven by Middle East war concerns and growing skepticism around AI valuations weigh on the stock, despite its central role in the AI boom. Sysco Corp: Sysco announced a $29 billion acquisition of Jetro Restaurant Depot to expand its reach in the independent restaurant market, though shares fell on concerns about increased debt financing."
Market News & Insights Jun 12, 2024

Nvidia Stock Faces Price Correction Concerns

Nvidia Corporation (NVDA: NYE) has been a darling of the stock market, riding the wave of artificial intelligence (AI) innovation. But is…

#Artificial Intelligence #technology stocks
Novavax Eyes Long-Term Growth with New Vaccines
Market News & Insights Jun 12, 2024

Novavax Eyes Long-Term Growth with New Vaccines

Shares of Novavax (NVAX: NSD) plummeted as the initial wave of panic surrounding COVID-19 subsided. Investors rushed to buy stocks of companies…

#Healthcare Stocks #U.S. Markets

Posts pagination

Previous 1 … 198 199 200 201 202 … 301 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.